Anna Holmes

609 total citations
14 papers, 412 citations indexed

About

Anna Holmes is a scholar working on Dermatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Anna Holmes has authored 14 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Anna Holmes's work include Acne and Rosacea Treatments and Effects (6 papers), Herpesvirus Infections and Treatments (4 papers) and Dermatology and Skin Diseases (4 papers). Anna Holmes is often cited by papers focused on Acne and Rosacea Treatments and Effects (6 papers), Herpesvirus Infections and Treatments (4 papers) and Dermatology and Skin Diseases (4 papers). Anna Holmes collaborates with scholars based in United States, Australia and Ireland. Anna Holmes's co-authors include Martin Steinhoff, Julia Spoendlin, Hilary Baldwin, Anne Lynn S. Chang, Anna L. Chien, Helen J. Chenery, David A. Copland, Peter A. Silburn, Anna Di Nardo and Eugene Huang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Psychopharmacology.

In The Last Decade

Anna Holmes

13 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Holmes United States	8	347	105	75	65	45	14	412
Carine Rosignoli France	6	356 1.0×	107 1.0×	99 1.3×	66 1.0×	45 1.0×	6	446
Mathias Sulk Germany	9	857 2.5×	227 2.2×	190 2.5×	191 2.9×	50 1.1×	17	993
Yunzhu Mu China	9	191 0.6×	85 0.8×	16 0.2×	9 0.1×	44 1.0×	18	309
Thomas Volksdorf Germany	7	164 0.5×	23 0.2×	16 0.2×	12 0.2×	96 2.1×	7	340
Yeşim Kaymak Türkiye	9	286 0.8×	108 1.0×	21 0.3×	21 0.3×	82 1.8×	16	351
Caroline Sousa Costa Brazil	8	255 0.7×	98 0.9×	25 0.3×	15 0.2×	48 1.1×	16	313
Arash Akhavan United States	10	213 0.6×	38 0.4×	77 1.0×	9 0.1×	32 0.7×	12	411
Philippe Andrès France	11	267 0.8×	90 0.9×	26 0.3×	5 0.1×	46 1.0×	16	365
Victor Georgescu France	11	208 0.6×	24 0.2×	21 0.3×	7 0.1×	21 0.5×	19	286
Ana Cláudia Cavalcante Espósito Brazil	13	374 1.1×	279 2.7×	17 0.2×	7 0.1×	17 0.4×	41	479

Countries citing papers authored by Anna Holmes

Since Specialization

Citations

This map shows the geographic impact of Anna Holmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Holmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Holmes more than expected).

Fields of papers citing papers by Anna Holmes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Holmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Holmes. The network helps show where Anna Holmes may publish in the future.

Co-authorship network of co-authors of Anna Holmes

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Holmes. A scholar is included among the top collaborators of Anna Holmes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Holmes. Anna Holmes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wolfe, Cameron R., Jonathan Cohen, Anna Holmes, et al.. (2025). Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY). Clinical Infectious Diseases. 81(3). 439–450. 1 indexed citations

Popejoy, Myra W., et al.. (2024). A phase 3 study to evaluate efficacy and safety of VYD222, an IgG1 monoclonal antibody for prevention of COVID-19 (CANOPY): Subset analysis of participants with significant immune compromise in the setting of solid tumor or hematologic malignancies.. Journal of Clinical Oncology. 42(16_suppl). 2532–2532.

Ison, Michael G., Debra F. Weinstein, Anna Holmes, et al.. (2023). Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE). Open Forum Infectious Diseases. 10(7). ofad314–ofad314. 7 indexed citations

Holmes, Anna, Julia Spoendlin, Anna L. Chien, Hilary Baldwin, & Anne Lynn S. Chang. (2017). Evidence-based update on rosacea comorbidities and their common physiologic pathways. Journal of the American Academy of Dermatology. 78(1). 156–166. 85 indexed citations

Holmes, Anna & Martin Steinhoff. (2016). Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Experimental Dermatology. 26(8). 659–667. 130 indexed citations

Nardo, Anna Di, et al.. (2016). Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial. Journal of the American Academy of Dermatology. 74(6). 1086–1092. 31 indexed citations

Docherty, James R., Martin Steinhoff, Dianne Lorton, et al.. (2016). Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy. Advances in Therapy. 33(11). 1885–1895. 13 indexed citations

Holmes, Anna, et al.. (2015). Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies.. PubMed. 8(8). 29–35. 8 indexed citations

Holmes, Anna. (2013). Potential role of microorganisms in the pathogenesis of rosacea. Journal of the American Academy of Dermatology. 69(6). 1025–1032. 101 indexed citations

10.

Holmes, Anna, David A. Copland, Peter A. Silburn, & Helen J. Chenery. (2011). Nicotine effects on general semantic priming in Parkinson's disease.. Experimental and Clinical Psychopharmacology. 19(3). 215–223. 5 indexed citations

11.

Holmes, Anna, David A. Copland, Peter A. Silburn, & Helen J. Chenery. (2011). Acute nicotine enhances strategy-based semantic processing in Parkinson's disease. The International Journal of Neuropsychopharmacology. 14(7). 877–885. 18 indexed citations

12.

Holmes, Anna, Helen J. Chenery, & David A. Copland. (2010). Nicotine does not enhance basic semantic priming. Psychopharmacology. 211(3). 259–265. 1 indexed citations

13.

Holmes, Anna, Helen J. Chenery, & David A. Copland. (2007). Transdermal nicotine modulates strategy-based attentional semantic processing in non-smokers. The International Journal of Neuropsychopharmacology. 11(3). 389–99. 10 indexed citations

14.

Chenery, Helen J., Anna Holmes, John C. L. Ingram, & Elizabeth Cardell. (2003). Temporal constraints on summation of activation in Broca’s aphasia: Evidence from a triplet-priming task. Brain and Language. 87(1). 99–100. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact